DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kim GA, Lim YS, An J. , et al.
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.
Gut 2014;
63 (08) 1325-1332
We do not assume any responsibility for the contents of the web pages of other providers.